Paul Ware v. HHS - Influenza, Guillain-Barré syndrome (2022)
Case summary [AI summaries can sometimes make mistakes]
Paul Ware filed a petition on December 4, 2019, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he developed Guillain-Barré syndrome (GBS) as a result of an influenza vaccine he received on December 19, 2016.
The respondent denied that Mr. Ware sustained GBS, denied that he sustained a Table injury within the specified timeframe, and denied that the flu vaccine caused or significantly aggravated his alleged injury.
Despite these denials, both parties agreed to settle the case through a stipulation dated April 26, 2022. Special Master Katherine E.
Oler reviewed the file and adopted the parties' stipulation as her decision. The stipulation awarded Mr.
Ware a lump sum of $205,000.00, payable by check to Petitioner, as compensation for all damages available under the Vaccine Program. The decision directed the Clerk of the Court to enter judgment accordingly, unless a motion for review was filed.
Theory of causation
Paul Ware filed a petition on December 4, 2019, alleging Guillain-Barré syndrome (GBS) following an influenza vaccine on December 19, 2016. Respondent denied GBS, a Table injury, and causation/aggravation. The parties stipulated to settle, and Special Master Katherine E. Oler adopted the stipulation. The award was a lump sum of $205,000.00. The public decision does not describe the specific theory of causation, medical experts, onset, symptoms, tests, or treatments.
Source PDFs
USCOURTS-cofc-1_19-vv-01844